JPH0364143B2 - - Google Patents

Info

Publication number: JPH0364143B2
Authority: JP; Japan
Prior art keywords: urinary catheter; antibacterial agent; sustained release; ammonium salt; salt
Prior art date: 1983-10-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP58188942A

Other languages

English (en)

Japanese (ja)

Other versions

JPS6080458A (ja

Inventor

Masatsugu Mochizuki

Yoshihiro Umemura

Izumi Sakamoto

Kunihiko Takagi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Unitika Ltd

Original Assignee

Unitika Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-10-07

Filing date

1983-10-07

Publication date

1991-10-04

1983-10-07 Application filed by Unitika Ltd filed Critical Unitika Ltd

1983-10-07 Priority to JP58188942A priority Critical patent/JPS6080458A/ja

1985-05-08 Publication of JPS6080458A publication Critical patent/JPS6080458A/ja

1991-10-04 Publication of JPH0364143B2 publication Critical patent/JPH0364143B2/ja

Status Granted legal-status Critical Current

Links

230000002485 urinary effect Effects 0.000 claims description 39
239000003242 anti bacterial agent Substances 0.000 claims description 35
229920001971 elastomer Polymers 0.000 claims description 17
239000000806 elastomer Substances 0.000 claims description 16
229920000620 organic polymer Polymers 0.000 claims description 13
150000003242 quaternary ammonium salts Chemical class 0.000 claims description 13
238000013268 sustained release Methods 0.000 claims description 11
239000012730 sustained-release form Substances 0.000 claims description 11
239000004800 polyvinyl chloride Substances 0.000 claims description 5
229920000915 polyvinyl chloride Polymers 0.000 claims description 5
239000010410 layer Substances 0.000 claims description 4
229920002635 polyurethane Polymers 0.000 claims description 4
239000004814 polyurethane Substances 0.000 claims description 4
244000043261 Hevea brasiliensis Species 0.000 claims description 3
239000011247 coating layer Substances 0.000 claims description 3
229920003052 natural elastomer Polymers 0.000 claims description 3
229920001194 natural rubber Polymers 0.000 claims description 3
229920003051 synthetic elastomer Polymers 0.000 claims description 3
239000005061 synthetic rubber Substances 0.000 claims description 3
150000003863 ammonium salts Chemical class 0.000 claims description 2
CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical group CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 claims description 2
WNBGYVXHFTYOBY-UHFFFAOYSA-N benzyl-dimethyl-tetradecylazanium Chemical group CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 WNBGYVXHFTYOBY-UHFFFAOYSA-N 0.000 claims description 2
QDYLMAYUEZBUFO-UHFFFAOYSA-N cetalkonium chloride Chemical group CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 QDYLMAYUEZBUFO-UHFFFAOYSA-N 0.000 claims description 2
SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical group C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 claims description 2
GLFDLEXFOHUASB-UHFFFAOYSA-N trimethyl(tetradecyl)azanium Chemical group CCCCCCCCCCCCCC[N+](C)(C)C GLFDLEXFOHUASB-UHFFFAOYSA-N 0.000 claims description 2
239000007788 liquid Substances 0.000 description 11
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
238000012360 testing method Methods 0.000 description 9
210000001635 urinary tract Anatomy 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
229920005862 polyol Polymers 0.000 description 6
150000003077 polyols Chemical class 0.000 description 6
239000000126 substance Substances 0.000 description 6
210000002700 urine Anatomy 0.000 description 6
230000000844 anti-bacterial effect Effects 0.000 description 5
239000000243 solution Substances 0.000 description 5
238000007598 dipping method Methods 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000007654 immersion Methods 0.000 description 4
238000000034 method Methods 0.000 description 4
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
229920006173 natural rubber latex Polymers 0.000 description 4
-1 polytetramethylene Polymers 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
206010061218 Inflammation Diseases 0.000 description 3
239000002253 acid Substances 0.000 description 3
125000000217 alkyl group Chemical group 0.000 description 3
UYUFIKCFKMFRBU-UHFFFAOYSA-M benzyl-hexadecyl-dimethylazanium;iodide Chemical compound [I-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 UYUFIKCFKMFRBU-UHFFFAOYSA-M 0.000 description 3
230000007423 decrease Effects 0.000 description 3
DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
230000004054 inflammatory process Effects 0.000 description 3
229920000126 latex Polymers 0.000 description 3
239000004816 latex Substances 0.000 description 3
210000004877 mucosa Anatomy 0.000 description 3
239000004014 plasticizer Substances 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
239000013543 active substance Substances 0.000 description 2
WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
229920001519 homopolymer Polymers 0.000 description 2
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
239000000463 material Substances 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
239000000178 monomer Substances 0.000 description 2
125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920001228 polyisocyanate Polymers 0.000 description 2
239000005056 polyisocyanate Substances 0.000 description 2
229920001451 polypropylene glycol Polymers 0.000 description 2
CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
210000003932 urinary bladder Anatomy 0.000 description 2
208000019206 urinary tract infection Diseases 0.000 description 2
235000014692 zinc oxide Nutrition 0.000 description 2
239000011787 zinc oxide Substances 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
ZXHZWRZAWJVPIC-UHFFFAOYSA-N 1,2-diisocyanatonaphthalene Chemical compound C1=CC=CC2=C(N=C=O)C(N=C=O)=CC=C21 ZXHZWRZAWJVPIC-UHFFFAOYSA-N 0.000 description 1
PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 1
RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
GOJCZVPJCKEBQV-UHFFFAOYSA-N Butyl phthalyl butylglycolate Chemical compound CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC GOJCZVPJCKEBQV-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
206010008111 Cerebral haemorrhage Diseases 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
239000004803 Di-2ethylhexylphthalate Substances 0.000 description 1
244000286663 Ficus elastica Species 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
JCELWOGDGMAGGN-UHFFFAOYSA-N N=C=O.N=C=O.C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 Chemical compound N=C=O.N=C=O.C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 JCELWOGDGMAGGN-UHFFFAOYSA-N 0.000 description 1
MRWSBLWWDRNONW-UHFFFAOYSA-N P(=O)(OCCCC)(OC1(C(C=CC=C1)C)C)OC1(C(C=CC=C1)C)C Chemical compound P(=O)(OCCCC)(OC1(C(C=CC=C1)C)C)OC1(C(C=CC=C1)C)C MRWSBLWWDRNONW-UHFFFAOYSA-N 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
235000017284 Pometia pinnata Nutrition 0.000 description 1
240000007653 Pometia tomentosa Species 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
206010046543 Urinary incontinence Diseases 0.000 description 1
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
RPRLOOOPNHXYAL-UHFFFAOYSA-K [O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1.CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1.CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 Chemical compound [O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1.CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1.CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 RPRLOOOPNHXYAL-UHFFFAOYSA-K 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000001361 adipic acid Substances 0.000 description 1
235000011037 adipic acid Nutrition 0.000 description 1
125000004183 alkoxy alkyl group Chemical group 0.000 description 1
JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
230000003712 anti-aging effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
229960003872 benzethonium Drugs 0.000 description 1
BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
230000009172 bursting Effects 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
BEWFIPLBFJGWSR-UHFFFAOYSA-N butyl 12-acetyloxyoctadec-9-enoate Chemical compound CCCCCCC(OC(C)=O)CC=CCCCCCCCC(=O)OCCCC BEWFIPLBFJGWSR-UHFFFAOYSA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
125000004181 carboxyalkyl group Chemical group 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
238000000748 compression moulding Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
238000007334 copolymerization reaction Methods 0.000 description 1
239000011162 core material Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
201000003146 cystitis Diseases 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
150000001991 dicarboxylic acids Chemical class 0.000 description 1
PUFGCEQWYLJYNJ-UHFFFAOYSA-N didodecyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCCC PUFGCEQWYLJYNJ-UHFFFAOYSA-N 0.000 description 1
150000001993 dienes Chemical class 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
XWVQUJDBOICHGH-UHFFFAOYSA-N dioctyl nonanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCC(=O)OCCCCCCCC XWVQUJDBOICHGH-UHFFFAOYSA-N 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002612 dispersion medium Substances 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
238000010828 elution Methods 0.000 description 1
208000005053 encephalomalacia Diseases 0.000 description 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000000945 filler Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000007789 gas Substances 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
GEAWFZNTIFJMHR-UHFFFAOYSA-N hepta-1,6-diene Chemical compound C=CCCCC=C GEAWFZNTIFJMHR-UHFFFAOYSA-N 0.000 description 1
PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
150000002483 hydrogen compounds Chemical class 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
239000012948 isocyanate Substances 0.000 description 1
150000002513 isocyanates Chemical class 0.000 description 1
LADVLFVCTCHOAI-UHFFFAOYSA-N isocyanic acid;toluene Chemical compound N=C=O.CC1=CC=CC=C1 LADVLFVCTCHOAI-UHFFFAOYSA-N 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000000465 moulding Methods 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
239000003345 natural gas Substances 0.000 description 1
201000008383 nephritis Diseases 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
239000006916 nutrient agar Substances 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
150000003021 phthalic acid derivatives Chemical class 0.000 description 1
PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920006295 polythiol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
BPJZKLBPJBMLQG-KWRJMZDGSA-N propanoyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OC(=O)CC BPJZKLBPJBMLQG-KWRJMZDGSA-N 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
239000005060 rubber Substances 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
208000020431 spinal cord injury Diseases 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
239000003206 sterilizing agent Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical class OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
208000000143 urethritis Diseases 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000004073 vulcanization Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
239000008096 xylene Substances 0.000 description 1
DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)

JP58188942A 1983-10-07 1983-10-07 抗菌剤徐放性導尿カテ−テル Granted JPS6080458A (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP58188942A JPS6080458A (ja)	1983-10-07	1983-10-07	抗菌剤徐放性導尿カテ−テル

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP58188942A JPS6080458A (ja)	1983-10-07	1983-10-07	抗菌剤徐放性導尿カテ−テル

Publications (2)

Publication Number	Publication Date
JPS6080458A JPS6080458A (ja)	1985-05-08
JPH0364143B2 true JPH0364143B2 (de)	1991-10-04

Family

ID=16232601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP58188942A Granted JPS6080458A (ja)	1983-10-07	1983-10-07	抗菌剤徐放性導尿カテ−テル

Country Status (1)

Country	Link
JP (1)	JPS6080458A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0781566A2 (de)	1995-12-26	1997-07-02	Toyo Boseki Kabushiki Kaisha	In organischen Lösungsmitteln lösliche Mucopolysaccharide, antibakterielles antithrombogenes Mittel und medizinisches Material

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2636838B2 (ja) *	1986-01-13	1997-07-30	ユニチカ株式会社	抗菌剤徐放性導尿カテーテル
JPH0638843B2 (ja) *	1986-10-15	1994-05-25	東洋クロス株式会社	感染防止性を有する抗菌性構造物
EP0520160A1 (de) *	1991-06-28	1992-12-30	BOC HEALTH CARE, Inc.	Verfahren zur antimikrobiellen Behandlung von Polyurethan

1983
- 1983-10-07 JP JP58188942A patent/JPS6080458A/ja active Granted

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0781566A2 (de)	1995-12-26	1997-07-02	Toyo Boseki Kabushiki Kaisha	In organischen Lösungsmitteln lösliche Mucopolysaccharide, antibakterielles antithrombogenes Mittel und medizinisches Material

Also Published As

Publication number	Publication date
JPS6080458A (ja)	1985-05-08

Publication	Publication Date	Title
EP0141628B1 (de)	1989-10-18	Antimikrobielle Latexmischung, Formkörper daraus und Verfahren zur Herstellung eines Formkörpers
US6589591B1 (en)	2003-07-08	Method for treating medical devices using glycerol and an antimicrobial agent
DE60116052T2 (de)	2006-08-31	Polymermischungen als bioabbaubare matrizen zur herstellung von biokompositen
EP2167564B1 (de)	2014-04-09	Antimikrobielle polyurethanharze und daraus hergestellte produkte
EP0379271A2 (de)	1990-07-25	Anti-infektiöse, gleitfähige, medizinische Gegenstände und Verfahren zu deren Herstellung
US20100074932A1 (en)	2010-03-25	Antimicrobial compositions containing gallium
JPH0261261B2 (de)	1990-12-19
EP2416731B1 (de)	2014-12-03	Medizingeräte mit nitroprussid und antimikrobiellen wirkstoffen
AU2002320366A1 (en)	2003-05-22	Method for treating medical devices using glycerol and an antimicrobial agent
WO1994024181A1 (en)	1994-10-27	Encrustation and bacterial resistant coatings for medical applications
DE10242476A1 (de)	2004-03-25	Antibiotikum-/Antibiotika-Polymer-Kombination
JPH0328224B2 (de)	1991-04-18
JP2008513172A (ja)	2008-05-01	医療機器及び医療機器を製造する方法
JPH0364143B2 (de)	1991-10-04
JPH0310341B2 (de)	1991-02-13
EP4057814A1 (de)	2022-09-21	Antimikrobielle und antivirale biologisch aktive polymerverbundstoffe mit wirksamkeit gegen sars-cov-2 und andere virale, bakterielle und fungale ziele sowie verwandte verfahren, materialien, beschichtungen und vorrichtungen
JPH0474026B2 (de)	1992-11-25
JP2636838B2 (ja)	1997-07-30	抗菌剤徐放性導尿カテーテル
EP0520160A1 (de)	1992-12-30	Verfahren zur antimikrobiellen Behandlung von Polyurethan
Zhang et al.	2017	Antimicrobial modifications on critical care implants
JPH0327213B2 (de)	1991-04-15
JPS5995057A (ja)	1984-05-31	導尿カテ−テルの製造方法
Szycher	2015	Polyurethanes: Antimicrobial
JPH036822B2 (de)	1991-01-31
HK1036599B (en)	2005-10-28	Moulded items made from active substance-containing thermoplastic polyurethanes

JPH0364143B2 - - Google Patents

Info

Links

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (2)

Family

ID=16232601

Family Applications (1)

Country Status (1)

Cited By (1)

Families Citing this family (3)

Cited By (1)

Also Published As

Similar Documents